Registered Malawi · PMRA

UNIGEL COMBINATION PRODUCT SUSPENSION

MAGALDRATE & SIMETHICONE

PMPB/PL126/86 SUSPENSION alimentary tract and metabolism INN generic

What it does

Magaldrate is a medication used to relieve symptoms of excess stomach acid, such as heartburn and indigestion.

Commonly used for: heartburn, indigestion, stomach upset

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL126/86
Registration date
17/04/2015
Expiry date
30/06/2016
Status
Registered
Active ingredient
MAGALDRATE & SIMETHICONE
Dosage form
SUSPENSION
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
A02AD - Combinations and complexes of aluminium, calcium and magnesium compounds
RxNorm RxCUI
29151
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-15 04:32:42

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About magaldrate

Magaldrate is a medication used to relieve symptoms of excess stomach acid, such as heartburn and indigestion.

What it treats

  • heartburn
  • indigestion
  • stomach upset

How it works

It works by neutralizing stomach acid, which helps reduce discomfort.

Who it's for

It is suitable for adults and children experiencing symptoms related to too much stomach acid.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About simethicone

Simethicone is a medicine that helps relieve discomfort caused by gas in the stomach and intestines.

What it treats

  • bloating
  • gas pain
  • flatulence

How it works

Simethicone works by breaking up gas bubbles in the stomach and intestines, making it easier for the body to eliminate them.

Who it's for

This medicine is suitable for adults and children experiencing gas-related discomfort.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: magaldrate

BNF-referenced

Magaldrate is an inorganic compound comprised of aluminum and magnesium hydroxides. It is primarily used as an antacid to neutralize stomach acid, providing relief from symptoms of dyspepsia, gastroesophageal reflux disease (GERD), and peptic ulcer disease. Its formulation allows for a combination of aluminum and magnesium ions, which helps to minimize the side effects often associated with aluminum-based antacids, such as constipation.

Indications

  • Dyspepsia
  • Gastroesophageal reflux disease (GERD)
  • Peptic ulcer disease
  • Heartburn

Dosage

Children: Refer to the BNF for Children for specific pediatric dosing guidance.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Magaldrate works by neutralizing gastric acid through a chemical reaction that produces water and salts. It promotes a more alkaline environment in the stomach, which helps to alleviate symptoms of acid-related disorders. The presence of both aluminum and magnesium ions allows for a balanced effect, as magnesium can counteract the constipating effects of aluminum.

Pharmacodynamics

The pharmacodynamic effects of magaldrate involve the reduction of gastric acidity, leading to increased gastric pH. This action helps to relieve heartburn, indigestion, and discomfort associated with excess stomach acid. The combination of aluminum and magnesium also contributes to a more prolonged effect, as they act synergistically to enhance the antacid properties.

Pharmacokinetics

Magaldrate is generally not absorbed systemically; rather, it acts locally in the gastrointestinal tract. The onset of action is typically rapid, providing quick relief of symptoms. The duration of action can vary based on the formulation and dosage but generally lasts for several hours. Renal impairment may affect the elimination of aluminum and magnesium, necessitating caution in patients with compromised kidney function.

Adverse effects

  • Constipation
  • Diarrhea
  • Nausea
  • Abdominal pain

Precautions

  • Use with caution in patients with renal impairment
  • Monitor patients with electrolyte disturbances

Pregnancy

Magaldrate can be used during pregnancy if necessary, but it is advisable to consult a healthcare professional.

Breast-feeding

Magaldrate is considered safe during breastfeeding but should be used under medical supervision.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

  • Oral suspension
  • Tablets

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: simethicone

BNF-referenced

Simethicone is a medication that functions as an antifoaming agent, primarily used to relieve symptoms of excess gas in the gastrointestinal tract. It works by reducing the surface tension of gas bubbles, which helps them to coalesce and be expelled from the body. It is often utilized in the management of conditions characterized by bloating and discomfort due to gas, such as flatulence and gastroesophageal reflux disease.

Indications

  • Flatulence
  • Bloating
  • Gastroesophageal reflux disease
  • Functional dyspepsia

Dosage

Children: For children, refer to the BNF for Children for specific dosing recommendations.

Adults: The usual adult dose is 40 to 125 mg taken after meals and at bedtime, as needed.

Mechanism of action

Simethicone is a surfactant that decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion. It acts by forming a film of low surface tension that promotes the coalescence of mucus-surrounded gas bubbles, allowing for easier passage of gas.

Pharmacodynamics

Simethicone decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion. Its effects are generally short-lived, as it is typically administered as needed. The therapeutic index is wide since it is not absorbed systemically, making it safe for use in various patient populations.

Pharmacokinetics

Simethicone is not systemically absorbed following oral administration, which contributes to its safety profile. Due to its lack of systemic absorption, specific pharmacokinetic parameters such as half-life, clearance, and volume of distribution are not applicable.

Pregnancy

Simethicone can be used during pregnancy as there are no known risks associated with its use.

Breast-feeding

Simethicone is considered safe to use during breastfeeding, as it is not absorbed systemically.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Oral suspension
  • Chewable tablets
  • Soft gels

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: magaldrate

PubChem CID 122706784

Molecular formula: Al5H33Mg10O40S2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: simethicone

PubChem CID 6433516

Molecular formula: C6H18O4Si3

Mechanism of action

Simethicone is a surfactant that decreases the surface tension of gas bubbles in the gastrointestinal tract, more easily allowing gas to exit the body. The clinical use of simethicone is based on its antifoam properties. Silicone antifoams spread on the surface of aqueous liquids, forming a film of low surface tension and thus causing collapse of foam bubbles. Simethicone reportedly allows mucus-surrounded gas bubbles in the GI tract to coalesce and be expelled.

Pharmacodynamics

Simethicone decreases the surface tension of gas bubbles in the gastrointestinal tract, facilitating their expulsion. It has a short duration of action as it is generally given as needed, and a wide therapeutic index as it is not systemically absorbed.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.